Copyright thenationonlineng
German pharmaceutical giant Bayer partners Nigeria’s ChroMedix on new facility The Federal Government of Nigeria and the European Union, through the Presidential Initiative for Unlocking the Healthcare Value Chain (PVAC), have signed three Memoranda of Understanding (MOUs) to strengthen healthcare distribution, supply, and local manufacturing in Nigeria. Frontlined by an MoU signed between German Pharmaceutical Giant, Bayer, and Nigeria’s ChroMedix to establish a reproductive health products manufacturing facility in Anambra State, the MoUs signed between the European Union and the Federal Government ensure enhanced distribution of pharmaceutical products for the public market in Nigeria; local manufacturing capacity development for essential reproductive health products in Nigeria and articulated technology transfer of selected technologies and/or manufacturing steps to Nigeria. Read Also: AFCON 2025: Ivorian Bamba omits Super Eagles from likely title contenders The agreements were formalised during the Nigeria–EU Health Investment Forum in Abuja, themed “Made in Nigeria, Made for Health,” where Dr. Abdu Mukhtar, National Coordinator of PVAC, stated that the partnerships would significantly enhance local production of healthcare products, tapping into a market currently valued at $46 billion.
